- A researcher is studying chemotaxis of neutrophils toward a site of infection. The inflammatory exudate is found to contain high levels of C3a and C5a. While both are anaphylatoxins, blockade of the receptor for which molecule would most severely impair neutrophil recruitment?
Answer: C5a, as it is a significantly more potent chemotactic agent for neutrophils.
While both C3a and C5a are inflammatory mediators (anaphylatoxins), C5a is the most potent complement-derived chemotactic factor for neutrophils, attracting them to the site of inflammation. Although more C3a is produced (A), the chemotactic potency of C5a is far greater, making it the critical driver of neutrophil recruitment. C5a also activates mast cells (C is not unique to C3a). C5a is not an opsonin; C3b is (D).
- A patient with paroxysmal nocturnal hemoglobinuria (PNH) has a deficiency in GPI-anchored proteins, including CD59 (protectin). This deficiency leads to complement-mediated intravascular hemolysis. Which specific step in the complement cascade is uncontrolled on the patient's erythrocytes?
Answer: Polymerization of C9 to complete the membrane attack complex pore.
CD59 (protectin) is a key regulatory protein that prevents the final step of the membrane attack complex (MAC) formation. Specifically, it inhibits the binding and polymerization of C9 within the C5b-8 complex. In its absence, the MAC (C5b-9) can fully assemble on host cells like erythrocytes, leading to lysis. The other steps (A, B) are regulated by other proteins (like DAF and Factor H), and C1q binding (C) requires antibody, which is not the primary mechanism in PNH.
- The 'tick-over' mechanism is fundamental to the readiness of the alternative complement pathway. This process involves the spontaneous, low-level hydrolysis of which component?
Answer: C3, forming C3(H₂O) which can bind Factor B.
The alternative complement pathway maintains constant surveillance through a clever "tick-over" mechanism that keeps the system primed for activation. Understanding this background process is crucial for grasping how complement responds so rapidly to threats.
The tick-over mechanism centers on the spontaneous hydrolysis of C3 in plasma. Under normal physiological conditions, C3 molecules randomly undergo slow, low-level hydrolysis of their internal thioester bond, converting them to C3(H₂O). This hydrolyzed form has a conformation similar to activated C3b, allowing it to bind Factor B. When Factor B associates with C3(H₂O), Factor D can cleave it to produce the Bb fragment, forming a C3(H₂O)Bb complex that acts as a weak C3 convertase. This creates a continuous, low-level production of actual C3b molecules that can initiate full pathway activation when they encounter activating surfaces.
Choice B incorrectly suggests Factor B hydrolyzes spontaneously - Factor B only becomes reactive after binding to C3(H₂O) and being cleaved by Factor D. Choice C misidentifies C5 as the spontaneously hydrolyzing component; C5 is cleaved later in the pathway by C5 convertases, not through spontaneous hydrolysis. Choice D incorrectly positions properdin as the initial hydrolyzing molecule; properdin actually stabilizes existing convertases rather than initiating the tick-over process.
Remember that complement tick-over always starts with C3 - it's the central component whose spontaneous activation keeps the alternative pathway ready to respond. Focus on C3's unique ability to undergo spontaneous thioester bond hydrolysis when studying complement regulation.
- The complement system is activated by a Gram-negative bacterium. Which of the following molecules functions both as a component of a C5 convertase and as a potent opsonin?
Answer: C3b
C3b is the central molecule of the complement system. It is the primary opsonin, coating pathogen surfaces for phagocytosis. It is also a critical component of the C5 convertases of all pathways (C4b2a3b in classical/lectin and C3bBbC3b in alternative). C4b is a weak opsonin and part of the classical C5 convertase but not the alternative one. C5b initiates MAC but is not an opsonin. Bb is the catalytic subunit of the alternative pathway convertases.
- Which of the following describes a key difference between the C3 convertase of the lectin pathway and the C3 convertase of the alternative pathway?
Answer: The lectin pathway convertase contains C2a, while the alternative pathway convertase contains Bb.
The C3 convertase of the lectin pathway is C4b2a, which is identical to the classical pathway convertase. The C3 convertase of the alternative pathway is C3bBb. Therefore, the key difference is the catalytic subunit: C2a in the lectin pathway versus Bb in the alternative pathway. Properdin stabilizes the alternative pathway convertase, not the lectin one (B is reversed). Neither C3 convertase can cleave C5 directly; they must first bind another C3b molecule to become a C5 convertase (C). Both pathways are designed to activate on pathogen surfaces, not host cells (D).
- The membrane attack complex (MAC) is effective at lysing certain pathogens. Its lytic activity is significantly more potent against Escherichia coli than against Staphylococcus aureus primarily because of differences in which of the following structures?
Answer: Thickness of the peptidoglycan cell wall.
E. coli is a Gram-negative bacterium with a thin peptidoglycan layer situated between two cell membranes. The MAC can readily insert into the outer membrane and lyse the cell. S. aureus is a Gram-positive bacterium with a very thick, external peptidoglycan wall that acts as a physical barrier, preventing the MAC from accessing and disrupting the underlying cell membrane. While LPS (A) can be a PAMP that activates complement, it doesn't prevent MAC function. Mannose (C) is relevant for lectin pathway activation, not MAC efficacy. Capsules (D) can inhibit complement activation in general, but the fundamental difference in MAC susceptibility between these two bacterial types is the cell wall structure.
- A novel strain of Neisseria gonorrhoeae is found to secrete a protein that acts as a potent C3 convertase inhibitor, effective against both the classical and alternative pathway convertases. Which downstream event of the complement cascade would be the earliest to be completely blocked by this inhibitor?
Answer: Generation of the inflammatory mediator C5a.
All complement pathways converge at the formation of C3 convertase, which cleaves C3. The next major step is the formation of C5 convertase (by adding C3b to C3 convertase) and the subsequent cleavage of C5 into C5a and C5b. If the C3 convertase is inhibited, C5 convertase cannot form, and C5a cannot be generated. Choices A, C, and D are all upstream events that occur before the action of C3 convertase and would not be blocked by its inhibitor.
- The initiation of the lectin complement pathway most closely resembles the initiation of the classical pathway in that both:
Answer: involve proteases that cleave C4 and C2.
The lectin pathway is initiated by MBL binding to carbohydrates, which activates the MASP-1/MASP-2 proteases. The classical pathway is initiated by C1q binding to antibody, which activates the C1r/C1s proteases. Despite different initiating molecules, the subsequent step is homologous: both MASPs and C1s are proteases that cleave C4 and C2 to form the C4b2a C3 convertase. Spontaneous C3 hydrolysis (A) is for the alternative pathway. Only the classical pathway binds immunoglobulin (C). Properdin stabilizes the alternative pathway convertase (D).
- During the assembly of the Membrane Attack Complex (MAC), which component or complex is responsible for inserting into the lipid bilayer of the target cell, thereby providing an anchor for the subsequent assembly of the pore?
Answer: The C5b-7 complex
When you encounter questions about the Membrane Attack Complex (MAC), focus on the sequential assembly process and which components actually penetrate the target cell membrane. The MAC formation is a carefully orchestrated cascade where each step enables the next.
The C5b-7 complex is the critical membrane-insertion unit that initiates pore formation. When C7 joins the C5b-6 complex, it undergoes a conformational change that exposes hydrophobic regions, allowing the entire C5b-7 complex to insert into the lipid bilayer. This insertion provides the essential membrane anchor that positions and stabilizes the growing MAC structure for subsequent component assembly.
Let's examine why the other options miss the mark. Option B (C5b-6 complex) represents an earlier assembly intermediate that remains hydrophilic and cannot penetrate membranes—it requires C7 to gain membrane-insertion capability. Option C (C8 protein) binds to the already membrane-anchored C5b-7 complex and helps initiate the pore, but it's not the initial anchoring component. Option D (C9 monomer) polymerizes to form the final transmembrane pore, but this occurs only after the C5b-7 foundation is already established in the membrane.
The correct answer is A—the C5b-7 complex serves as the membrane anchor that makes all subsequent MAC assembly possible.
Study tip: Remember the MAC assembly sequence: C5b-6 forms in solution → C7 addition creates the membrane-inserting C5b-7 → C8 joins → C9 polymerizes. The transition from soluble to membrane-bound occurs specifically at the C5b-7 stage.
- Which event represents the most significant amplification step within the complement cascade, regardless of the initiating pathway?
Answer: The enzymatic cleavage of many C3 molecules by a single C3 convertase.
The most significant amplification point in all complement pathways is the C3 convertase step. A single C3 convertase enzyme (C4b2a or C3bBb) can cleave hundreds to thousands of C3 molecules. This results in a massive deposition of C3b on the pathogen surface, amplifying the opsonization signal and providing components for C5 convertase formation. While other steps involve some multiplication (e.g., C9 polymerization), they do not match the scale of amplification at the C3 cleavage stage.
- A genetic deficiency in properdin (Factor P) would most directly lead to a reduced ability to mount a robust response against which type of threat?
Answer: Bacterial pathogens in a host lacking specific antibodies.
Properdin is a positive regulator that stabilizes the C3bBb C3 convertase of the alternative pathway. The alternative pathway is crucial for innate, antibody-independent recognition of pathogens. Therefore, a properdin deficiency impairs this pathway, reducing the response to bacteria in a primary infection before antibodies are produced. Responses to antibody-coated cells (A) or immune complexes (D) rely on the classical pathway. Responses to high-mannan fungi (C) primarily use the lectin pathway. While all pathways can be involved, the most direct and severe impairment is to the alternative pathway.
- A patient with a deficiency in C8 would have a similar clinical susceptibility profile to a patient with a deficiency in which other complement component?
Answer: C6
C8 and C6 are both components of the terminal pathway that forms the Membrane Attack Complex (MAC), which consists of C5b, C6, C7, C8, and C9. A deficiency in any of these components impairs MAC formation, leading to a characteristic susceptibility to recurrent infections by Neisseria species. Deficiencies in C1q (A), C3 (B), or Factor B (C) would affect upstream pathways and have a broader range of clinical consequences, including impaired opsonization and inflammation, in addition to impaired MAC formation.
- A therapeutic monoclonal antibody is engineered to have a mutation in its Fc region that prevents it from binding C1q. When this antibody is used to target a bacterial pathogen, which complement-mediated effector function will be directly abolished?
Answer: Initiation of the classical pathway via immune complexes.
When you encounter questions about monoclonal antibodies and complement, focus on understanding which complement pathway is being affected and how that impacts downstream functions.
The Fc region of antibodies contains the binding site for C1q, the first component of the classical complement pathway. When antibodies bind to pathogens and form immune complexes, C1q recognizes and binds to the Fc regions, initiating the classical pathway cascade. If the Fc region is mutated to prevent C1q binding, this critical first step cannot occur, directly abolishing classical pathway initiation via immune complexes (A).
Let's examine why the other options remain unaffected: (B) is incorrect because alternative pathway C3 convertase stabilization occurs independently through factors like properdin and doesn't require antibody-C1q interaction. The alternative pathway uses different recognition mechanisms (like microbial surfaces) rather than immune complexes. (C) is wrong because C3b opsonization can still occur through the alternative pathway, which remains functional since it bypasses the C1q-dependent classical pathway initiation. (D) is incorrect because neutrophil recruitment by C5a can still happen via the alternative pathway, which can proceed to generate C5 convertase and subsequent C5a production without requiring classical pathway activation.
Remember this key principle: when antibody function is impaired, focus on what's directly dependent on that specific antibody mechanism. The classical pathway uniquely requires antibody-antigen immune complexes for C1q recognition, making it the most vulnerable to Fc region mutations affecting C1q binding.
- A researcher identifies a bacterial species that evades the alternative complement pathway by promoting the binding of a host regulatory protein to C3b on its surface. This mechanism most likely involves mimicry of a host cell surface molecule that binds which regulator?
Answer: Factor H
Host cells protect themselves from the alternative pathway by expressing surface molecules, such as sialic acid, that promote the binding of Factor H. Factor H then displaces Bb from C3b and acts as a cofactor for Factor I-mediated cleavage of C3b. A bacterium that mimics this host mechanism would promote Factor H binding to its own surface to shut down complement activation. C1-INH (A) regulates the classical pathway. DAF (B) and CD59 (D) are host-cell-bound proteins, not fluid-phase regulators recruited to the surface in the same way as Factor H.
- A patient with systemic lupus erythematosus (SLE) shows laboratory results of low serum C3 and low serum C4. This pattern is most indicative of the chronic activation of which complement pathway?
Answer: The classical pathway, due to circulating immune complexes.
SLE is characterized by the production of autoantibodies, which form immune complexes. These immune complexes are potent activators of the classical pathway, starting with C1q binding. Activation of the classical pathway consumes both C4 and C2 (forming C4b2a) and subsequently C3. Therefore, low levels of both C4 and C3 strongly suggest classical pathway activation. The alternative pathway (A) would primarily consume C3, leaving C4 levels relatively normal. The lectin pathway (C) also consumes C4 and C3, but immune complex-mediated activation is the hallmark of SLE.
- A patient with a complete C2 deficiency is infected with an encapsulated bacterium. While the alternative and lectin pathways remain functional, which of the following complement-mediated activities will be most significantly impaired during the initial adaptive immune response to this pathogen?
Answer: C1q-mediated clearance of antibody-antigen immune complexes.
A C2 deficiency blocks the classical complement pathway. The classical pathway is initiated by C1q binding to antibody-antigen complexes. Therefore, the clearance of these immune complexes, a key function of the classical pathway, will be most significantly impaired. The alternative pathway (choice A and C) and lectin pathway are intact and can still lead to C3b deposition and subsequent MAC formation (partially addressing B), but the specific function tied to C1q and antibody is lost.
- A patient is found to have a complete deficiency of Mannose-Binding Lectin (MBL). This individual would likely have the most difficulty controlling infections during which specific period?
Answer: From 1 to 4 days post-infection, before an adaptive response is mounted.
The immune response has several phases. The immediate innate response (0-4 hours) relies on pre-formed effectors. The early induced innate response (4 hours to 4 days) is critical for controlling infection before adaptive immunity is engaged. The MBL/lectin pathway is a key component of this early induced phase, recognizing carbohydrates on pathogens without needing antibodies. A deficiency would create a window of vulnerability during this period. The alternative pathway contributes immediately (A), but the lectin pathway is a major induced component. The memory response (C) is dominated by antibodies activating the classical pathway. Chronic viral infections (D) rely more on T-cells and NK cells.
- In the context of the alternative complement pathway, what is the direct and immediate function of Factor D?
Answer: To cleave Factor B once it has bound to C3b.
Factor D is a serine protease that circulates in an active form. Its specific role in the alternative pathway is to cleave Factor B into Ba and Bb, but only after Factor B has formed a complex with C3b. This cleavage results in the formation of the active C3 convertase, C3bBb. Properdin (not Factor D) stabilizes this complex (A). C3 hydrolysis is spontaneous (B), and decay-accelerating factor (DAF) or Factor H mediate displacement (D).
- A patient with hereditary angioedema has a deficiency in C1 inhibitor (C1-INH). This leads to unregulated activity of C1, which in turn results in the excessive cleavage of which two complement proteins, leading to their depletion?
Answer: C4 and C2
C1 inhibitor (C1-INH) regulates the C1 complex (C1qrs). In its absence, activated C1s becomes overactive. The natural substrates for C1s are C4 and C2. Uncontrolled C1s activity leads to continuous cleavage and consumption of C4 and C2, causing their serum levels to be very low. While this can lead to some downstream C3 consumption, the primary and most marked depletion is of the direct substrates, C4 and C2. (The main symptoms of angioedema are due to C1-INH's effect on the kinin system, but the effect on complement is the depletion of C4 and C2).
- Factor H is a critical fluid-phase regulator of the complement system. Its primary regulatory function involves which of the following mechanisms?
Answer: Binding to C3b and accelerating the decay of the alternative pathway C3 convertase.
Factor H is a key regulator of the alternative pathway. It competes with Factor B for binding to C3b and also accelerates the dissociation (decay) of the C3bBb complex once formed. It also acts as a cofactor for Factor I-mediated cleavage of C3b. Factor H preferentially binds to C3b on host cells (which are rich in sialic acid), thus protecting them from damage. C1 inhibitor (C1-INH) inhibits C1s (A). CD59 prevents C9 polymerization (C). Factor I, with cofactors like C4bp, cleaves C4b (D).
